Evidence Based Mediocrity

  • by: |
  • 02/04/2008
Anyone who has taken a look at the recent research review Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer should say a prayer that the EBM thought police do not get control over the practice of medicine in America under the banner of cost containment OR conflict of interest. The "guidelines", if you can call them that, are drivel, essentially conceding two points: First, that patient and tumor characateristics heavily influence treatment selections and do so over the course of disease. Second -- and by extension -- that clinical expertise matters. But of course many oncologist with the best expertise fail the holier than thou COI standard imposed by those who hide their agenda under the purity banner (the capitalism=corruption=corrupt medicine coalition). As the panels to decide what is best practice are picked, you can be sure that their will be tribunals, inquests, witchhunts and general suppression of the ability of any one who consults with pharma or biotech companies, anyone who has a research contract or runs a clinical trial for a drug company will be purged of participation. This is nothing short than an attack on intellectual freedom as harsh and as unrelenting as anything seen in the sciences or liberal arts in recent years. And this is not a matter of forcing college kids to do research on reasons why Bush should be impeached. This boils down to a bunch of autocrats trying to dictate to the rest of us a politically correct form of medicine....

For a taste of force-fed medicine to come:

http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=9&DocID=79
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog